1. Coward JI, Middleton K, Murphy F (2016) New perspectives on targeted therapy in ovarian cancer. Int J Womens Health 7:189–203
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917
3. Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C (2013;24 Suppl 6) Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol:vi24–vi32
4. Foley OW, Rauh-Hain JA, Carmen MG (2013) Recurrent epithelial ovarian cancer: an update on treatment. Oncology (Williston Park) 27(4):288–294 298
5. Mantia-Smaldone GM, Edwards RP, Vlad AM (2011) Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies. Cancer Manag Res 3:25–38